Suppr超能文献

卵巢颗粒细胞瘤:临床特征、治疗、结局及预后因素。

Ovarian granulosa cell tumor: clinical features, treatment, outcome, and prognostic factors.

作者信息

Khosla Divya, Dimri Kislay, Pandey Awadhesh K, Mahajan Rohit, Trehan Romeeta

机构信息

Department of Radiotherapy and Oncology, Government Medical College and Hospital, Chandigarh, India.

出版信息

N Am J Med Sci. 2014 Mar;6(3):133-8. doi: 10.4103/1947-2714.128475.

Abstract

BACKGROUND

Granulosa cell tumors are rare neoplasms characterized by long natural history and favorable prognosis.

AIMS

The objective of this study was to determine the clinical presentation, treatment, outcome, and prognostic factors for patients of granulosa cell tumors.

MATERIALS AND METHODS

A retrospective analysis of 26 patients of granulosa cell tumor of ovary from 2002 to 2011 was carried out. The records of all patients were analyzed to determine clinical presentation, treatment, survival, and prognostic factors.

RESULTS

The median age of the patients was 50 years (range, 17-71 years). Abdominal pain was the most common presenting symptom. The median follow-up was 71.4 months (range, 21.6-149.9 months). The estimated 5 and 10 year overall survival (OS) was 84.6 and 72.5%, respectively. Event-free survival (EFS) was 76.5 and 52.9% at 5 and 10 years, respectively. Advanced stage was significant independent poor prognostic indicator for both OS and EFS.

CONCLUSION

Majority of the patients with granulosa cell tumors of the ovary present in early stage. Surgery is the primary treatment modality for granulosa cell tumors. Advanced stage and presence of residual disease were associated with inferior survival, but only prospective studies can ascertain their definite role.

摘要

背景

颗粒细胞瘤是一种罕见的肿瘤,其自然病程较长,预后良好。

目的

本研究的目的是确定颗粒细胞瘤患者的临床表现、治疗、结局及预后因素。

材料与方法

对2002年至2011年期间26例卵巢颗粒细胞瘤患者进行回顾性分析。分析所有患者的记录,以确定临床表现、治疗、生存情况及预后因素。

结果

患者的中位年龄为50岁(范围17 - 71岁)。腹痛是最常见的首发症状。中位随访时间为71.4个月(范围21.6 - 149.9个月)。估计5年和10年总生存率(OS)分别为84.6%和72.5%。无事件生存率(EFS)在5年和10年时分别为76.5%和52.9%。晚期是OS和EFS的显著独立不良预后指标。

结论

大多数卵巢颗粒细胞瘤患者处于早期。手术是颗粒细胞瘤的主要治疗方式。晚期和残留疾病的存在与较差的生存率相关,但只有前瞻性研究才能确定它们的确切作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/3978936/6dcc0c35e20b/NAJMS-6-133-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验